General Information of the Compound
| Compound ID |
CP0954131
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(Benzo[d]oxazol-6-yl)-(6R*)-N6-(4-pyrrolidin-1-yl-butyl)-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H33ClN4O3
|
||||||||||||||||||
| Molecular Weight |
485.028
|
||||||||||||||||||
| Canonical SMILES |
Cl.O=C(NCCCCN1CCCC1)[C@H]1[C@H](C(=O)Nc2ccc3ncoc3c2)[C@@H]2C=C[C@H]1C21CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H32N4O3.ClH/c31-24(27-11-1-2-12-30-13-3-4-14-30)22-18-6-7-19(26(18)9-10-26)23(22)25(32)29-17-5-8-20-21(15-17)33-16-28-20;/h5-8,15-16,18-19,22-23H,1-4,9-14H2,(H,27,31)(H,29,32);1H/t18-,19+,22-,23-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GGMISHVMZHIBJF-AZHYNHOSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2